Sandoz’s Enzeevu secures FDA approval for nAMD treatment

In individuals with nAMD, aflibercept is injected into the eye to enhance visual acuity and slow disease progression. Credit: Rudy and Peter Skitterians from Pixabay.



  • Sandoz